Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs Sufentanil for Postoperative Analgesia and Neuro‑Immune Outcomes in Elderly Spinal Tuberculosis Surgery
ChiCTR2500115441Phase 4Not yet recruiting
- Sponsor
- Hebei Province Chest Hospital
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in postoperative pain, delirium, Immunodeficiency syndrome (IDS) and 1 more (2 arms), sponsored by Hebei Province Chest Hospital. Primary endpoint: Visual Analogue Scale (VAS) pain score at rest and during cough. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative paindeliriumImmunodeficiency syndrome (IDS)spinal tuberculosis
Beyond the preview
Go deeper on ChiCTR2500115441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500115441.